Clinical Research Details

Clinical Research

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects with Painful Diabetic Peripheral Neuropathy (VMDN-003/C)

Study Description

The purpose of this study is to assess the safety and efficacy of bilateral intramuscular (IM) injection of VM202 in the calves of subjects with painful diabetic peripheral neuropathy (DPN).

Subjects will be ranodmized to treatment with study drug or placebo.

Open Enrollment

Contact Name: Kamala Weldon
Contact Phone: (904) 633-1801
Contact Email:


Principal Investigator
Joe M. Chehade, M.D.

Sub Investigator
Kent R. Wehmeier, M.D.